Following National Advertising Division Challenge, Summus Medical Laser Voluntarily Discontinues Certain Claims
New York, NY – June 4, 2024 – Following a BBB National Programs’ National Advertising Division challenge brought by competitor Multi Radiance Medical, Summus Medical Laser voluntarily discontinued certain claims for its Medical Laser product.
Multi Radiance Medical challenged claims that it argued were outside the indications allowed by the Food and Drug Administration (FDA) for devices registered under product code ILY for temporary relief of minor muscle and joint pain, arthritis, and muscle spasms, relieving stiffness, promoting relaxation of muscle tissue, and to temporarily increase local blood circulation where heat is indicated.
In response to the challenge, Summus stated that it is permanently discontinuing the challenged claims. Therefore, the National Advertising Division (NAD) did not review the claims on their merits and will treat the claims, for compliance purposes, as though NAD recommended they be discontinued.
In its advertiser statement, Summus stated that it agrees to comply with NAD’s recommendations and appreciates the opportunity to participate in the self-regulatory process.
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB procedures, this release shall not be used for advertising or promotional purposes.
Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.
Latest Decisions
Direct Selling Self-Regulatory Council Recommends MONAT Discontinue Earnings Claims
McLean, VA – September 5, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended MONAT Global discontinue certain earnings claims made on the MONAT website and by salesforce members on Facebook, Twitter/X, Instagram, and YouTube.
National Advertising Division Refers HiSmile Teeth Whitening Product Claims to the Federal Trade Commission
National Advertising Division Refers Comparative Efficacy Claims for HiSmile Toothbrushes to Regulatory Authorities for Further Review
New York, NY – August 29, 2024 – The National Advertising Division referred advertising claims made by HiSmile for its toothbrushes to the Federal Trade Commission (FTC) and other regulatory authorities for review after HiSmile declined to participate in the industry self-regulation process.
National Advertising Division Finds Certain Claims for Verizon Home Internet Supported; Recommends Verizon Modify or Discontinue Others
New York, NY – August 28, 2024 – In a challenge brought by Charter Communications, the National Advertising Division determined that Verizon provided a reasonable basis for certain claims for its Verizon Home Internet but recommended that it discontinue or modify others.